Structure

Physi-Chem Properties

Molecular Weight:  474.17
Volume:  488.512
LogP:  4.891
LogD:  3.521
LogS:  -6.183
# Rotatable Bonds:  8
TPSA:  95.97
# H-Bond Aceptor:  7
# H-Bond Donor:  0
# Rings:  4
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.278
Synthetic Accessibility Score:  3.235
Fsp3:  0.286
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  2

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.865
MDCK Permeability:  2.559476524766069e-05
Pgp-inhibitor:  0.998
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.004
20% Bioavailability (F20%):  0.007
30% Bioavailability (F30%):  0.054

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.027
Plasma Protein Binding (PPB):  99.22010040283203%
Volume Distribution (VD):  0.377
Pgp-substrate:  1.348573088645935%

ADMET: Metabolism

CYP1A2-inhibitor:  0.462
CYP1A2-substrate:  0.867
CYP2C19-inhibitor:  0.932
CYP2C19-substrate:  0.186
CYP2C9-inhibitor:  0.946
CYP2C9-substrate:  0.891
CYP2D6-inhibitor:  0.313
CYP2D6-substrate:  0.721
CYP3A4-inhibitor:  0.937
CYP3A4-substrate:  0.424

ADMET: Excretion

Clearance (CL):  3.55
Half-life (T1/2):  0.043

ADMET: Toxicity

hERG Blockers:  0.083
Human Hepatotoxicity (H-HT):  0.134
Drug-inuced Liver Injury (DILI):  0.924
AMES Toxicity:  0.572
Rat Oral Acute Toxicity:  0.448
Maximum Recommended Daily Dose:  0.491
Skin Sensitization:  0.042
Carcinogencity:  0.681
Eye Corrosion:  0.003
Eye Irritation:  0.065
Respiratory Toxicity:  0.031

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC3898

Natural Product ID:  NPC3898
Common Name*:   DSDQYPOXSDSSCO-UHFFFAOYSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  DSDQYPOXSDSSCO-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C28H26O7/c1-28(2,14-21-23(29)17-10-6-7-11-18(17)24(30)25(21)31)15-35-27(32)20-13-22(33-3)16-9-5-8-12-19(16)26(20)34-4/h5-13,31H,14-15H2,1-4H3
SMILES:  COc1c(cc(c2c1cccc2)OC)C(=O)OCC(CC1=C(O)C(=O)c2c(C1=O)cccc2)(C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL184182
PubChem CID:   NA
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0000023] Naphthalenes
        • [CHEMONTID:0001871] Naphthalenecarboxylic acids and derivatives
          • [CHEMONTID:0002421] Naphthalenecarboxylic acids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO3049 Rhinacanthus nasutus Species Acanthaceae Eukaryota n.a. n.a. n.a. PMID[8463799]
NPO3049 Rhinacanthus nasutus Species Acanthaceae Eukaryota n.a. n.a. n.a. PMID[8792629]
NPO3049 Rhinacanthus nasutus Species Acanthaceae Eukaryota n.a. n.a. n.a. PMID[9214738]
NPO3049 Rhinacanthus nasutus Species Acanthaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO3049 Rhinacanthus nasutus Species Acanthaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO11678 Aeonium cuneatum Species Crassulaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO13891 Scolytus multistriatus Species Curculionidae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO11855 Streptomyces xanthocidicus Species Streptomycetaceae Bacteria n.a. n.a. n.a. Database[UNPD]
NPO14480 Tornabea scutellifera Species Physciaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO12707 Lithospermum canescens Species Boraginaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT91 Cell Line KB Homo sapiens IC50 = 350.0 nM PMID[503208]
NPT165 Cell Line HeLa Homo sapiens IC50 = 1090.0 nM PMID[503208]
NPT65 Cell Line HepG2 Homo sapiens IC50 = 970.0 nM PMID[503208]
NPT189 Cell Line Vero Chlorocebus aethiops IC50 = 32700.0 nM PMID[503208]
NPT91 Cell Line KB Homo sapiens IC50 = 350.0 nM PMID[503209]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC3898 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9866 High Similarity NPC67197
0.8816 High Similarity NPC300540
0.8733 High Similarity NPC149780
0.8693 High Similarity NPC211565
0.8693 High Similarity NPC60389
0.8675 High Similarity NPC69755
0.8636 High Similarity NPC478163
0.8625 High Similarity NPC284495
0.8609 High Similarity NPC124365
0.8608 High Similarity NPC66029
0.8581 High Similarity NPC474107
0.8571 High Similarity NPC147250
0.8562 High Similarity NPC89664
0.8562 High Similarity NPC274085
0.8553 High Similarity NPC474360
0.8544 High Similarity NPC477691
0.8506 High Similarity NPC478019
0.8497 Intermediate Similarity NPC53016
0.8497 Intermediate Similarity NPC476473
0.8494 Intermediate Similarity NPC477836
0.8494 Intermediate Similarity NPC473113
0.8481 Intermediate Similarity NPC477690
0.8477 Intermediate Similarity NPC477408
0.8477 Intermediate Similarity NPC470407
0.8471 Intermediate Similarity NPC205766
0.8467 Intermediate Similarity NPC471542
0.8462 Intermediate Similarity NPC472841
0.8457 Intermediate Similarity NPC24761
0.8456 Intermediate Similarity NPC281513
0.8456 Intermediate Similarity NPC22222
0.8447 Intermediate Similarity NPC324736
0.8438 Intermediate Similarity NPC279605
0.8438 Intermediate Similarity NPC469507
0.8435 Intermediate Similarity NPC205360
0.8431 Intermediate Similarity NPC474300
0.8424 Intermediate Similarity NPC76647
0.8415 Intermediate Similarity NPC71390
0.8415 Intermediate Similarity NPC26386
0.8411 Intermediate Similarity NPC475104
0.8397 Intermediate Similarity NPC119767
0.8397 Intermediate Similarity NPC478018
0.8393 Intermediate Similarity NPC186800
0.8377 Intermediate Similarity NPC163948
0.8377 Intermediate Similarity NPC66593
0.8375 Intermediate Similarity NPC478161
0.8375 Intermediate Similarity NPC226656
0.8375 Intermediate Similarity NPC478159
0.8375 Intermediate Similarity NPC66508
0.8365 Intermediate Similarity NPC175978
0.8365 Intermediate Similarity NPC281272
0.8364 Intermediate Similarity NPC477835
0.8355 Intermediate Similarity NPC1268
0.8355 Intermediate Similarity NPC476191
0.8354 Intermediate Similarity NPC294646
0.8344 Intermediate Similarity NPC472261
0.8344 Intermediate Similarity NPC186647
0.8344 Intermediate Similarity NPC301341
0.8333 Intermediate Similarity NPC477692
0.8323 Intermediate Similarity NPC221992
0.8323 Intermediate Similarity NPC477409
0.8322 Intermediate Similarity NPC470406
0.8313 Intermediate Similarity NPC473094
0.8302 Intermediate Similarity NPC39819
0.8302 Intermediate Similarity NPC230848
0.8299 Intermediate Similarity NPC57552
0.8291 Intermediate Similarity NPC70764
0.8284 Intermediate Similarity NPC470667
0.8282 Intermediate Similarity NPC476506
0.8278 Intermediate Similarity NPC155211
0.8278 Intermediate Similarity NPC232996
0.8278 Intermediate Similarity NPC471670
0.8272 Intermediate Similarity NPC317580
0.8272 Intermediate Similarity NPC263483
0.8269 Intermediate Similarity NPC474630
0.8269 Intermediate Similarity NPC49282
0.8267 Intermediate Similarity NPC27394
0.8267 Intermediate Similarity NPC1249
0.8263 Intermediate Similarity NPC473095
0.8263 Intermediate Similarity NPC473096
0.8261 Intermediate Similarity NPC318270
0.8253 Intermediate Similarity NPC30027
0.825 Intermediate Similarity NPC24232
0.825 Intermediate Similarity NPC164912
0.825 Intermediate Similarity NPC154683
0.825 Intermediate Similarity NPC44606
0.825 Intermediate Similarity NPC40356
0.8247 Intermediate Similarity NPC283292
0.8247 Intermediate Similarity NPC257003
0.8239 Intermediate Similarity NPC470568
0.8239 Intermediate Similarity NPC290954
0.8239 Intermediate Similarity NPC147735
0.8239 Intermediate Similarity NPC144010
0.8239 Intermediate Similarity NPC255641
0.8239 Intermediate Similarity NPC474660
0.8235 Intermediate Similarity NPC256463
0.8235 Intermediate Similarity NPC471602
0.8235 Intermediate Similarity NPC306835
0.8235 Intermediate Similarity NPC29771
0.8235 Intermediate Similarity NPC111422
0.8235 Intermediate Similarity NPC299405
0.8235 Intermediate Similarity NPC476477
0.8235 Intermediate Similarity NPC216312
0.8228 Intermediate Similarity NPC172329
0.8228 Intermediate Similarity NPC2569
0.8224 Intermediate Similarity NPC245923
0.8224 Intermediate Similarity NPC284184
0.8221 Intermediate Similarity NPC326084
0.821 Intermediate Similarity NPC146211
0.8205 Intermediate Similarity NPC475813
0.8204 Intermediate Similarity NPC234331
0.8204 Intermediate Similarity NPC473945
0.8204 Intermediate Similarity NPC472660
0.8199 Intermediate Similarity NPC218870
0.8199 Intermediate Similarity NPC474824
0.8199 Intermediate Similarity NPC474622
0.8199 Intermediate Similarity NPC470408
0.8199 Intermediate Similarity NPC135522
0.8199 Intermediate Similarity NPC182921
0.8199 Intermediate Similarity NPC474621
0.8193 Intermediate Similarity NPC178281
0.8193 Intermediate Similarity NPC314653
0.8193 Intermediate Similarity NPC316262
0.8187 Intermediate Similarity NPC118427
0.8187 Intermediate Similarity NPC145830
0.8187 Intermediate Similarity NPC470569
0.8182 Intermediate Similarity NPC220496
0.8182 Intermediate Similarity NPC37992
0.8182 Intermediate Similarity NPC147542
0.8182 Intermediate Similarity NPC42262
0.8182 Intermediate Similarity NPC241349
0.8182 Intermediate Similarity NPC327916
0.8182 Intermediate Similarity NPC32749
0.8176 Intermediate Similarity NPC472298
0.8176 Intermediate Similarity NPC80370
0.8171 Intermediate Similarity NPC470342
0.8171 Intermediate Similarity NPC185617
0.8171 Intermediate Similarity NPC313368
0.8171 Intermediate Similarity NPC472060
0.8171 Intermediate Similarity NPC472052
0.8171 Intermediate Similarity NPC475449
0.8166 Intermediate Similarity NPC478002
0.8165 Intermediate Similarity NPC126767
0.8165 Intermediate Similarity NPC289042
0.8165 Intermediate Similarity NPC118027
0.8165 Intermediate Similarity NPC190648
0.8165 Intermediate Similarity NPC312929
0.8165 Intermediate Similarity NPC56433
0.8165 Intermediate Similarity NPC245584
0.8163 Intermediate Similarity NPC45537
0.816 Intermediate Similarity NPC44199
0.816 Intermediate Similarity NPC201127
0.8158 Intermediate Similarity NPC474813
0.8158 Intermediate Similarity NPC141934
0.8158 Intermediate Similarity NPC472308
0.8158 Intermediate Similarity NPC475549
0.8155 Intermediate Similarity NPC49487
0.8155 Intermediate Similarity NPC99613
0.8153 Intermediate Similarity NPC473951
0.8153 Intermediate Similarity NPC47152
0.8153 Intermediate Similarity NPC478160
0.8144 Intermediate Similarity NPC125465
0.8144 Intermediate Similarity NPC29160
0.8141 Intermediate Similarity NPC469885
0.8141 Intermediate Similarity NPC167663
0.8141 Intermediate Similarity NPC478164
0.8137 Intermediate Similarity NPC474534
0.8137 Intermediate Similarity NPC474533
0.8133 Intermediate Similarity NPC477689
0.8133 Intermediate Similarity NPC474340
0.8133 Intermediate Similarity NPC17432
0.8129 Intermediate Similarity NPC471444
0.8129 Intermediate Similarity NPC102053
0.8125 Intermediate Similarity NPC473466
0.8125 Intermediate Similarity NPC119929
0.8125 Intermediate Similarity NPC315520
0.8121 Intermediate Similarity NPC31539
0.8118 Intermediate Similarity NPC85368
0.8118 Intermediate Similarity NPC229051
0.8118 Intermediate Similarity NPC131862
0.8117 Intermediate Similarity NPC295339
0.8113 Intermediate Similarity NPC95526
0.8113 Intermediate Similarity NPC5537
0.811 Intermediate Similarity NPC186113
0.811 Intermediate Similarity NPC472299
0.811 Intermediate Similarity NPC471541
0.811 Intermediate Similarity NPC228654
0.8107 Intermediate Similarity NPC313304
0.8101 Intermediate Similarity NPC314437
0.8101 Intermediate Similarity NPC301949
0.8101 Intermediate Similarity NPC225173
0.8101 Intermediate Similarity NPC163846
0.8101 Intermediate Similarity NPC470570
0.8098 Intermediate Similarity NPC472453
0.8098 Intermediate Similarity NPC474861
0.8095 Intermediate Similarity NPC324522
0.8095 Intermediate Similarity NPC469521
0.8095 Intermediate Similarity NPC470341
0.8095 Intermediate Similarity NPC472058
0.8095 Intermediate Similarity NPC105414
0.8095 Intermediate Similarity NPC234497

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC3898 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8533 High Similarity NPD2346 Discontinued
0.8408 Intermediate Similarity NPD3226 Approved
0.8344 Intermediate Similarity NPD2935 Discontinued
0.8291 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.8247 Intermediate Similarity NPD7003 Approved
0.8182 Intermediate Similarity NPD6232 Discontinued
0.8144 Intermediate Similarity NPD7473 Discontinued
0.8114 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8086 Intermediate Similarity NPD7819 Suspended
0.8047 Intermediate Similarity NPD5844 Phase 1
0.8 Intermediate Similarity NPD2313 Discontinued
0.8 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7922 Intermediate Similarity NPD2799 Discontinued
0.7904 Intermediate Similarity NPD6959 Discontinued
0.7901 Intermediate Similarity NPD6599 Discontinued
0.7871 Intermediate Similarity NPD5404 Approved
0.7871 Intermediate Similarity NPD5406 Approved
0.7871 Intermediate Similarity NPD5408 Approved
0.7871 Intermediate Similarity NPD5405 Approved
0.7853 Intermediate Similarity NPD7411 Suspended
0.784 Intermediate Similarity NPD7458 Discontinued
0.7821 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7818 Intermediate Similarity NPD5402 Approved
0.7812 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7812 Intermediate Similarity NPD2533 Approved
0.7812 Intermediate Similarity NPD2532 Approved
0.7812 Intermediate Similarity NPD2534 Approved
0.7784 Intermediate Similarity NPD8150 Discontinued
0.7771 Intermediate Similarity NPD7768 Phase 2
0.7764 Intermediate Similarity NPD6273 Approved
0.7758 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7722 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7714 Intermediate Similarity NPD8312 Approved
0.7714 Intermediate Similarity NPD8313 Approved
0.7702 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7676 Intermediate Similarity NPD7435 Discontinued
0.7661 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7632 Intermediate Similarity NPD6832 Phase 2
0.7619 Intermediate Similarity NPD7075 Discontinued
0.7619 Intermediate Similarity NPD3749 Approved
0.7616 Intermediate Similarity NPD2798 Approved
0.7613 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7609 Intermediate Similarity NPD6777 Approved
0.7609 Intermediate Similarity NPD6779 Approved
0.7609 Intermediate Similarity NPD6778 Approved
0.7609 Intermediate Similarity NPD6776 Approved
0.7609 Intermediate Similarity NPD6780 Approved
0.7609 Intermediate Similarity NPD6781 Approved
0.7609 Intermediate Similarity NPD6782 Approved
0.76 Intermediate Similarity NPD1283 Approved
0.758 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7572 Intermediate Similarity NPD7177 Discontinued
0.7562 Intermediate Similarity NPD3750 Approved
0.755 Intermediate Similarity NPD1470 Approved
0.7548 Intermediate Similarity NPD2979 Phase 3
0.754 Intermediate Similarity NPD7870 Phase 2
0.754 Intermediate Similarity NPD7871 Phase 2
0.7531 Intermediate Similarity NPD7390 Discontinued
0.7531 Intermediate Similarity NPD6799 Approved
0.7529 Intermediate Similarity NPD5494 Approved
0.75 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD3817 Phase 2
0.7487 Intermediate Similarity NPD7696 Phase 3
0.7487 Intermediate Similarity NPD7697 Approved
0.7487 Intermediate Similarity NPD7698 Approved
0.7486 Intermediate Similarity NPD8434 Phase 2
0.7485 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD6801 Discontinued
0.7484 Intermediate Similarity NPD1471 Phase 3
0.7484 Intermediate Similarity NPD2344 Approved
0.7471 Intermediate Similarity NPD3751 Discontinued
0.747 Intermediate Similarity NPD4380 Phase 2
0.7468 Intermediate Similarity NPD4308 Phase 3
0.7468 Intermediate Similarity NPD7008 Discontinued
0.7468 Intermediate Similarity NPD3748 Approved
0.7453 Intermediate Similarity NPD4628 Phase 3
0.7453 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.744 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7438 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7435 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7435 Intermediate Similarity NPD7874 Approved
0.7434 Intermediate Similarity NPD1203 Approved
0.7421 Intermediate Similarity NPD1551 Phase 2
0.7419 Intermediate Similarity NPD3268 Approved
0.7419 Intermediate Similarity NPD411 Approved
0.7401 Intermediate Similarity NPD6559 Discontinued
0.74 Intermediate Similarity NPD1611 Approved
0.74 Intermediate Similarity NPD1281 Approved
0.7394 Intermediate Similarity NPD5403 Approved
0.7389 Intermediate Similarity NPD447 Suspended
0.7381 Intermediate Similarity NPD6844 Discontinued
0.7378 Intermediate Similarity NPD5401 Approved
0.7372 Intermediate Similarity NPD6233 Phase 2
0.7362 Intermediate Similarity NPD7236 Approved
0.7358 Intermediate Similarity NPD1510 Phase 2
0.7356 Intermediate Similarity NPD6166 Phase 2
0.7356 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7356 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7355 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7353 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7351 Intermediate Similarity NPD9717 Approved
0.7351 Intermediate Similarity NPD3972 Approved
0.7346 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7342 Intermediate Similarity NPD1607 Approved
0.7337 Intermediate Similarity NPD6534 Approved
0.7337 Intermediate Similarity NPD2801 Approved
0.7337 Intermediate Similarity NPD6535 Approved
0.733 Intermediate Similarity NPD7701 Phase 2
0.7325 Intermediate Similarity NPD4307 Phase 2
0.732 Intermediate Similarity NPD2797 Approved
0.7315 Intermediate Similarity NPD1651 Approved
0.7315 Intermediate Similarity NPD5691 Approved
0.7312 Intermediate Similarity NPD2438 Suspended
0.7312 Intermediate Similarity NPD2796 Approved
0.7308 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7308 Intermediate Similarity NPD6798 Discontinued
0.7301 Intermediate Similarity NPD2309 Approved
0.7289 Intermediate Similarity NPD920 Approved
0.7285 Intermediate Similarity NPD1201 Approved
0.7285 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD3412 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD4626 Approved
0.7263 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7251 Intermediate Similarity NPD3882 Suspended
0.7246 Intermediate Similarity NPD7239 Suspended
0.7241 Intermediate Similarity NPD5711 Approved
0.7241 Intermediate Similarity NPD3787 Discontinued
0.7241 Intermediate Similarity NPD7229 Phase 3
0.7241 Intermediate Similarity NPD5710 Approved
0.7239 Intermediate Similarity NPD8166 Discontinued
0.7222 Intermediate Similarity NPD1549 Phase 2
0.7219 Intermediate Similarity NPD5889 Approved
0.7219 Intermediate Similarity NPD7699 Phase 2
0.7219 Intermediate Similarity NPD5890 Approved
0.7219 Intermediate Similarity NPD7700 Phase 2
0.7216 Intermediate Similarity NPD7801 Approved
0.7215 Intermediate Similarity NPD4060 Phase 1
0.7215 Intermediate Similarity NPD1240 Approved
0.7208 Intermediate Similarity NPD3267 Approved
0.7208 Intermediate Similarity NPD3266 Approved
0.7205 Intermediate Similarity NPD2531 Phase 2
0.7202 Intermediate Similarity NPD8151 Discontinued
0.7197 Intermediate Similarity NPD3764 Approved
0.7189 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7189 Intermediate Similarity NPD6213 Phase 3
0.7189 Intermediate Similarity NPD6212 Phase 3
0.7184 Intermediate Similarity NPD1247 Approved
0.7178 Intermediate Similarity NPD2800 Approved
0.7176 Intermediate Similarity NPD1934 Approved
0.7175 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.717 Intermediate Similarity NPD1933 Approved
0.7169 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7168 Intermediate Similarity NPD919 Approved
0.7161 Intermediate Similarity NPD1019 Discontinued
0.716 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7158 Intermediate Similarity NPD6823 Phase 2
0.7152 Intermediate Similarity NPD8032 Phase 2
0.7152 Intermediate Similarity NPD7163 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD3300 Phase 2
0.7152 Intermediate Similarity NPD1778 Approved
0.7151 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.715 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD7095 Approved
0.7128 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7128 Intermediate Similarity NPD7783 Phase 2
0.7126 Intermediate Similarity NPD1512 Approved
0.7114 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.7114 Intermediate Similarity NPD9493 Approved
0.711 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7105 Intermediate Similarity NPD3496 Discontinued
0.7102 Intermediate Similarity NPD3926 Phase 2
0.7099 Intermediate Similarity NPD6100 Approved
0.7099 Intermediate Similarity NPD4476 Approved
0.7099 Intermediate Similarity NPD6099 Approved
0.7099 Intermediate Similarity NPD4477 Approved
0.7097 Intermediate Similarity NPD1164 Approved
0.7095 Intermediate Similarity NPD5951 Approved
0.7093 Intermediate Similarity NPD5616 Clinical (unspecified phase)
0.709 Intermediate Similarity NPD8285 Discontinued
0.7083 Intermediate Similarity NPD8320 Phase 1
0.7083 Intermediate Similarity NPD8319 Approved
0.7073 Intermediate Similarity NPD1243 Approved
0.7069 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD6355 Discontinued
0.7059 Intermediate Similarity NPD6585 Discontinued
0.7056 Intermediate Similarity NPD5953 Discontinued
0.7055 Intermediate Similarity NPD6800 Clinical (unspecified phase)
0.7048 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7045 Intermediate Similarity NPD6808 Phase 2
0.7035 Intermediate Similarity NPD1465 Phase 2
0.7032 Intermediate Similarity NPD1876 Approved
0.7013 Intermediate Similarity NPD1608 Approved
0.7006 Intermediate Similarity NPD1511 Approved
0.7 Intermediate Similarity NPD4140 Approved
0.7 Intermediate Similarity NPD5441 Clinical (unspecified phase)
0.6989 Remote Similarity NPD8127 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data